Opening Question Could a nasal spray be the breakthrough that millions of people with treatment-resistant depression have been waiting for? The FDA's recent approval of Spravato (esketamine) as a standalone treatment marks a historic moment in mental health care—but what do the clinical trial results...
What question is this article answering? What are the most effective, evidence-based treatment protocols for managing psychedelic-induced psychosis and HPPD (Hallucinogen Persisting Perception Disorder), and how can clinicians safely help patients who experience persistent adverse effects from psychedelic use? Synopsis: Recent clinical research has identified...
What question is this article answering? Is microdosing 5-MeO-DMT—often called the "God molecule"—actually safe, and what do the latest clinical trials tell us about the risks and benefits of this powerful psychedelic? Synopsis: Groundbreaking Phase 1 clinical trials have demonstrated that microdosing 5-MeO-DMT is remarkably...
What question is this article answering? Can psilocybin—the active compound in magic mushrooms—really help people quit smoking, and how does it compare to traditional smoking cessation methods? Synopsis: Groundbreaking clinical trials at Johns Hopkins have revealed that psilocybin-assisted therapy achieves smoking cessation rates of 67-80%—dramatically...